BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:02 PM
 | 
Aug 24, 2009
 |  BC Extra  |  Clinical News

Resolvyx reports dry eye data

Resolvyx Pharmaceuticals Inc. (Bedford, Mass.) said that in the Phase I/II 08-004-03 trial in 232 patients with moderate dry eye, topical RX-10045 twice daily met...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >